View Older Stories

Apr 13, 2026 07:00AM Theralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study

Apr 10, 2026 07:00AM Theralase(R) Closes $CAN 2.66 Million Financing

Mar 17, 2026 07:00AM Theralase(R) Discovers Further Mechanism on How Ruvidar(R) Inactivates Herpes Simplex Virus

Mar 10, 2026 07:02AM Theralase raises $1.1 million in private placement financing

Mar 10, 2026 07:00AM Theralase(R) Closes $1.1 M Non-Brokered Private Placement

Mar 9, 2026 07:00AM Theralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer

Mar 2, 2026 07:00AM Light-Activated Ruvidar and Interferon Demonstrate Enhanced Efficacy

Feb 20, 2026 07:00AM Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress

Feb 17, 2026 07:00AM Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress

Feb 10, 2026 07:00AM Theralase(R) Bladder Cancer Clinical Data to be Presented at the 2026 American Urological Association Annual Meeting

Feb 4, 2026 07:00AM Theralase(R) Provides Update on Bladder Cancer Clinical Study

Feb 2, 2026 07:00AM Theralase(R) Completes Enrollment in Bladder Cancer Clinical Study

Jan 12, 2026 07:00AM Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer

Dec 23, 2025 04:42PM Theralase raises $1.3M in private placement for cancer study

Dec 23, 2025 04:40PM Theralase(R) Closes $1.3 M Non-Brokered Private Placement

Dec 12, 2025 05:02PM Theralase launches $2 million private placement, ends brokered financing

Dec 12, 2025 05:00PM Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing

Nov 24, 2025 07:00AM Theralase(R) Announces Brokered LIFE Financing to Further Advance its Phase II Non-Muscle Invasive Bladder Cancer Clinical Study

Nov 17, 2025 07:00AM Theralase(R) Investor Conference Call Reminder

Nov 10, 2025 07:00AM Theralase(R) Releases 3Q2025 Financial Statements

Nov 3, 2025 07:00AM Theralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug

Sep 24, 2025 07:00AM Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex Virus

Aug 29, 2025 04:30PM Theralase(R) Extends Warrants

Aug 26, 2025 04:30PM Theralase(R) Releases 2Q2025 Financial Statements

Jul 28, 2025 07:00AM Theralase(R) Closes Non-Brokered Private Placement

Jun 27, 2025 04:30PM Theralase(R) Extends Warrants

Jun 17, 2025 07:00AM Theralase(R) Closes Non-Brokered Private Placement

Jun 12, 2025 07:00AM Theralase Completes Annual General and Special Meeting

Jun 5, 2025 07:00AM Theralase Annual General Meeting

May 30, 2025 07:00AM Theralase(R) 1Q2025 Financial Statements

May 29, 2025 04:30PM CORRECTION FROM SOURCE: Theralase to Present Groundbreaking Research at ASTRO 2025

May 28, 2025 07:00AM Theralase to Present Groundbreaking Research at ASTRO 2025

May 20, 2025 07:00AM Theralase Provides Corporate Update

May 5, 2025 07:00AM Theralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological Association

Apr 28, 2025 07:00AM Theralase Discovers New Mechanism of Action of Lead Drug

Apr 14, 2025 04:22PM Theralase(R) Closes Non-Brokered Private Placement

Apr 10, 2025 07:00AM Ruvidar More Effective in the Treatment of Herpes than FDA-Approved Treatments

Apr 7, 2025 07:00AM Ruvidar Demonstrates 7 Year Complete Response

Mar 24, 2025 07:00AM Ruvidar Effective in the Treatment of Herpes

Mar 12, 2025 07:00AM Theralase(R) Releases 2024 Annual Financial Statements

Mar 11, 2025 04:00PM Theralase(R) Closes Non-Brokered Private Placement

Mar 10, 2025 07:00AM Theralase(R) Therapy Improves Motor and Non-Motor Function in Parkinson's Patients

Feb 25, 2025 04:15PM Theralase(R) Demonstrates Efficacy of Rutherrin(R) in Destruction of Non-Hodgkin's Lymphoma

Feb 13, 2025 12:30PM CORRECTING AND REPLACING: Theralase(R) Demonstrates Effective Treatment of Herpes

Feb 12, 2025 04:15PM Theralase(R) Demonstrates Effective Treatment of Herpes

Feb 10, 2025 07:00AM Theralase(R) Releases Latest Research on Inactivation of Herpes Simplex Viruses

Jan 27, 2025 04:15PM Theralase(R) Interim Clinical Data to be Presented at the 2025 AUA Annual Meeting

Dec 9, 2024 08:05AM Theralase(R) Launches Three New Clinical Study Sites in USA

Dec 5, 2024 07:00AM Theralase(R) Launches New Clinical Study Site in Canada

Nov 27, 2024 05:05PM Theralase(R) Release’s 3Q2024 Financial Statements

View Older Stories